These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 35804871)

  • 1. Early Mortality among Patients with Head and Neck Cancer Diagnosed in Thuringia, Germany, between 1996 and 2016-A Population-Based Study.
    Kouka M; Buentzel J; Kaftan H; Boeger D; Mueller AH; Wittig A; Schultze-Mosgau S; Ernst T; Guntinas-Lichius O
    Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in epidemiology and treatment and outcome for head and neck cancer: a population-based long-term analysis from 1996 to 2011 of the Thuringian cancer registry.
    Guntinas-Lichius O; Wendt TG; Kornetzky N; Buentzel J; Esser D; Böger D; Müller A; Schultze-Mosgau S; Schlattmann P; Schmalenberg H
    Oral Oncol; 2014 Dec; 50(12):1157-64. PubMed ID: 25459063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender Disparities in Epidemiology, Treatment, and Outcome for Head and Neck Cancer in Germany: A Population-Based Long-Term Analysis from 1996 to 2016 of the Thuringian Cancer Registry.
    Dittberner A; Friedl B; Wittig A; Buentzel J; Kaftan H; Boeger D; Mueller AH; Schultze-Mosgau S; Schlattmann P; Ernst T; Guntinas-Lichius O
    Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33218009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic therapy for recurrent and/or metastatic head and neck cancer: a population-based healthcare research study in Thuringia, Germany.
    Morkramer L; Geitner M; Boeger D; Buentzel J; Kaftan H; Mueller AH; Ernst T; Guntinas-Lichius O
    J Cancer Res Clin Oncol; 2021 Sep; 147(9):2625-2635. PubMed ID: 33517469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Association between Patient's Age and Head and Neck Cancer Treatment Decision-A Population-Based Diagnoses-Related Group-Based Nationwide Study in Germany.
    Kouka M; Hermanns I; Schlattmann P; Guntinas-Lichius O
    Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Human Papillomavirus Status at Head and Neck Carcinoma Subsites With Overall Survival.
    Li H; Torabi SJ; Yarbrough WG; Mehra S; Osborn HA; Judson B
    JAMA Otolaryngol Head Neck Surg; 2018 Jun; 144(6):519-525. PubMed ID: 29801040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 25 year survival outcomes for squamous cell carcinomas of the head and neck: population-based outcomes from a Canadian province.
    Tiwana MS; Wu J; Hay J; Wong F; Cheung W; Olson RA
    Oral Oncol; 2014 Jul; 50(7):651-6. PubMed ID: 24731736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient Characteristics and Costs in Recurrent or Refractory Head and Neck Cancer: Retrospective Analysis of a Community Oncology Database.
    Fisher MD; Fernandes AW; Olufade TO; Miller PJ; Walker MS; Fenton M
    Clin Ther; 2018 Apr; 40(4):562-573. PubMed ID: 29530457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insurance status, stage of presentation, and survival among female patients with head and neck cancer.
    Panth N; Simpson MC; Sethi RKV; Varvares MA; Osazuwa-Peters N
    Laryngoscope; 2020 Feb; 130(2):385-391. PubMed ID: 30900256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival benefit of post-operative chemotherapy for intermediate-risk advanced stage head and neck cancer differs with patient age.
    Chen MM; Colevas AD; Megwalu U; Divi V
    Oral Oncol; 2018 Sep; 84():71-75. PubMed ID: 30115479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multilevel Associations Between Patient- and Hospital-Level Factors and In-Hospital Mortality Among Hospitalized Patients With Head and Neck Cancer.
    Adjei Boakye E; Osazuwa-Peters N; Chen B; Cai M; Tobo BB; Challapalli SD; Buchanan P; Piccirillo JF
    JAMA Otolaryngol Head Neck Surg; 2020 May; 146(5):444-454. PubMed ID: 32191271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early (90-day) mortality after radical radiotherapy for head and neck squamous cell carcinoma: A population-based analysis.
    Hamilton SN; Tran E; Berthelet E; Wu J; Olson R
    Head Neck; 2018 Nov; 40(11):2432-2440. PubMed ID: 30295975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Head and Neck Cancer With Mental Health Disorders in a Large Insurance Claims Database.
    Lee JH; Ba D; Liu G; Leslie D; Zacharia BE; Goyal N
    JAMA Otolaryngol Head Neck Surg; 2019 Apr; 145(4):339-344. PubMed ID: 30816930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second Primary Non-Small-Cell Lung Cancer After Head and Neck Cancer: A Population-Based Study of Clinical and Pathologic Characteristics and Survival Outcomes in 3597 Patients.
    Budnik J; DeNunzio NJ; Singh DP; Milano MT
    Clin Lung Cancer; 2020 May; 21(3):195-203. PubMed ID: 30914310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Head and neck cancer in Germany: a site-specific analysis of survival of the Thuringian cancer registration database.
    Guntinas-Lichius O; Wendt T; Buentzel J; Esser D; Lochner P; Mueller A; Schultze-Mosgau S; Altendorf-Hofmann A
    J Cancer Res Clin Oncol; 2010 Jan; 136(1):55-63. PubMed ID: 19568769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Socioeconomic disparities in head and neck cancer survival in Germany: a causal mediation analysis using population-based cancer registry data.
    Bedir A; Abera SF; Efremov L; Hassan L; Vordermark D; Medenwald D
    J Cancer Res Clin Oncol; 2021 May; 147(5):1325-1334. PubMed ID: 33569714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 30-day unplanned readmission rate in otolaryngology patients: A population-based study in Thuringia, Germany.
    Rippe W; Dittberner A; Boeger D; Buentzel J; Hoffmann K; Kaftan H; Mueller A; Radtke G; Guntinas-Lichius O
    PLoS One; 2019; 14(10):e0224146. PubMed ID: 31622434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is surgery necessary in stage III and stage IV cancer of the head and neck that responds to induction chemotherapy?
    Poulsen M; Aldren C; Tripcony L; Walker Q
    Arch Otolaryngol Head Neck Surg; 1996 May; 122(5):467-71. PubMed ID: 8615961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features and prognostic factors in patients with head and neck cancer: Results from a multicentric study.
    Leoncini E; Vukovic V; Cadoni G; Pastorino R; Arzani D; Bosetti C; Canova C; Garavello W; La Vecchia C; Maule M; Petrelli L; Pira E; Polesel J; Richiardi L; Serraino D; Simonato L; Ricciardi W; Boccia S
    Cancer Epidemiol; 2015 Jun; 39(3):367-74. PubMed ID: 25770642
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.